{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:35:48Z","timestamp":1791304548485,"version":"4.3.1"},"reference-count":242,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cell &amp; Developmental Biology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.semcdb.2016.02.009","type":"journal-article","created":{"date-parts":[[2016,2,7]],"date-time":"2016-02-07T03:45:21Z","timestamp":1454816721000},"page":"28-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":202,"special_numbering":"C","title":["STAT3 in the systemic inflammation of cancer cachexia"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7872-0540","authenticated-orcid":false,"given":"Teresa A.","family":"Zimmers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa L.","family":"Fishel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bonetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcdb.2016.02.009_bib0005","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nrd4467","article-title":"Muscle wasting in disease: molecular mechanisms and promising therapies","volume":"14","author":"Cohen","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0010","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.coph.2015.04.003","article-title":"Cachexia and sarcopenia: mechanisms and potential targets for intervention","volume":"22","author":"Argiles","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0015","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0020","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3892\/or.2010.815","article-title":"Nutrition in oncology: the case of micronutrients (review)","volume":"24","author":"Strohle","year":"2010","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0025","article-title":"Computed tomography-defined muscle and fat wasting are associated with cancer clinical outcomes","author":"Kazemi-Bajestani","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0030","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.bbrc.2009.12.123","article-title":"Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia","volume":"391","author":"Benny Klimek","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0035","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0040","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.jamda.2014.09.007","article-title":"Treatment of cachexia: an overview of recent developments","volume":"15","author":"von Haehling","year":"2014","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0045","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1517\/14656566.2015.1041500","article-title":"Anamorelin hydrochloride for the treatment of cancer\u2013anorexia\u2013cachexia in NSCLC","volume":"16","author":"Zhang","year":"2015","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0050","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/SPC.0000000000000091","article-title":"Role of interleukin-6 in cachexia: therapeutic implications","volume":"8","author":"Narsale","year":"2014","journal-title":"Curr. Opin. Supportive Palliat. Care"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0055","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1172\/JCI115767","article-title":"Evidence for the involvement of interleukin 6 in experimental cancer cachexia","volume":"89","author":"Strassmann","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0060","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/ni.3153","article-title":"IL-6 as a keystone cytokine in health and disease","volume":"16","author":"Hunter","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0065","first-page":"998","article-title":"Skeletal muscle glycoprotein 130\u2019s role in Lewis lung carcinoma-induced cachexia","volume":"28","author":"Puppa","year":"2014","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0070","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJMoa1002028","article-title":"Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis","volume":"363","author":"Verstovsek","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0075","doi-asserted-by":"crossref","first-page":"E410","DOI":"10.1152\/ajpendo.00039.2012","article-title":"JAK\/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia","volume":"303","author":"Bonetto","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0080","doi-asserted-by":"crossref","first-page":"11177","DOI":"10.1074\/jbc.M115.641514","article-title":"Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia","volume":"290","author":"Silva","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0085","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nrc3818","article-title":"Revisiting STAT3 signalling in cancer: new and unexpected biological functions","volume":"14","author":"Yu","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"Pt 2","key":"10.1016\/j.semcdb.2016.02.009_bib0090","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/bj3340297","article-title":"Interleukin-6-type cytokine signalling through the gp130\/Jak\/STAT pathway","volume":"334","author":"Heinrich","year":"1998","journal-title":"Biochem. J."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0095","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/08977194.2012.660936","article-title":"Biology and significance of the JAK\/STAT signalling pathways","volume":"30","author":"Kiu","year":"2012","journal-title":"Growth Factors (Chur, Switzerland)"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0100","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1073\/pnas.94.8.3801","article-title":"Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality","volume":"94","author":"Takeda","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0105","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.2741\/3597","article-title":"Regulation of hematopoietic cell development and function by Stat3","volume":"14","author":"Hankey","year":"2009","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0110","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/cvr\/cvu034","article-title":"STAT3, a key regulator of cell-to-cell communication in the heart","volume":"102","author":"Haghikia","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0115","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1038\/sj.onc.1203551","article-title":"Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors","volume":"19","author":"Hirano","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0120","doi-asserted-by":"crossref","first-page":"5665","DOI":"10.1158\/1078-0432.CCR-06-2491","article-title":"Targeting the cytoplasmic and nuclear functions of signal transducers and activators of transcription 3 for cancer therapy","volume":"13","author":"Germain","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0125","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0014-5793(01)02354-7","article-title":"Ser727-dependent transcriptional activation by association of p300 with STAT3 upon IL-6 stimulation","volume":"495","author":"Schuringa","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj20030407","article-title":"Principles of interleukin (IL)-6-type cytokine signalling and its regulation","volume":"374","author":"Heinrich","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0135","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.canlet.2006.10.017","article-title":"STAT3 as a central mediator of neoplastic cellular transformation","volume":"251","author":"Frank","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0140","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1105166","article-title":"Stat3 dimerization regulated by reversible acetylation of a single lysine residue","volume":"307","author":"Yuan","year":"2005","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0145","doi-asserted-by":"crossref","first-page":"11528","DOI":"10.1074\/jbc.M413930200","article-title":"Activation of Stat3 sequence-specific DNA binding and transcription by p300\/CREB-binding protein-mediated acetylation","volume":"280","author":"Wang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0150","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1053\/j.gastro.2005.07.055","article-title":"STAT3 NH2-terminal acetylation is activated by the hepatic acute-phase response and required for IL-6 induction of angiotensinogen","volume":"129","author":"Ray","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0155","doi-asserted-by":"crossref","first-page":"30763","DOI":"10.1074\/jbc.M114.603894","article-title":"Critical role for lysine 685 in gene expression mediated by transcription factor unphosphorylated STAT3","volume":"289","author":"Dasgupta","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0160","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1128\/MCB.00034-14","article-title":"Signal integration and gene induction by a functionally distinct STAT3 phosphoform","volume":"34","author":"Waitkus","year":"2014","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0165","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1158\/0008-5472.939.65.3","article-title":"Novel roles of unphosphorylated STAT3 in oncogenesis and transcriptional regulation","volume":"65","author":"Yang","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0170","doi-asserted-by":"crossref","first-page":"e22538","DOI":"10.1371\/journal.pone.0022538","article-title":"STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia","volume":"6","author":"Bonetto","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0175","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.18632\/oncotarget.2812","article-title":"Sunitinib prevents cachexia and prolongs survival of mice bearing renal cancer by restraining STAT3 and MuRF-1 activation in muscle","volume":"6","author":"Pretto","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0180","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.bbadis.2014.12.015","article-title":"Sex differences in the relationship of IL-6 signaling to cancer cachexia progression","volume":"1852","author":"Hetzler","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0185","doi-asserted-by":"crossref","first-page":"19976","DOI":"10.1074\/jbc.M115.638411","article-title":"A key role for leukemia inhibitory factor in C26 cancer cachexia","volume":"290","author":"Seto","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0190","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1242\/bio.20136544","article-title":"Characterization of the male ApcMin\/+ mouse as a hypogonadism model related to cancer cachexia","volume":"2","author":"White","year":"2013","journal-title":"Biol. Open"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0195","doi-asserted-by":"crossref","first-page":"e0119888","DOI":"10.1371\/journal.pone.0119888","article-title":"Liver inflammation and metabolic signaling in ApcMin\/+ mice: the role of cachexia progression","volume":"10","author":"Narsale","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0200","doi-asserted-by":"crossref","first-page":"e92966","DOI":"10.1371\/journal.pone.0092966","article-title":"Depletion of white adipose tissue in cancer cachexia syndrome is associated with inflammatory signaling and disrupted circadian regulation","volume":"9","author":"Tsoli","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0205","doi-asserted-by":"crossref","first-page":"R393","DOI":"10.1152\/ajpregu.00716.2007","article-title":"Interleukin-6 and cachexia in ApcMin\/+ mice","volume":"294","author":"Baltgalvis","year":"2008","journal-title":"Am. J. Physiol. Regul. Integr. Comparative Physiol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0210","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/jcp.24580","article-title":"Pancreatic cancer-induced cachexia is Jak2-dependent in mice","volume":"229","author":"Gilabert","year":"2014","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0215","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1517\/14728222.2013.830105","article-title":"gp130: a promising drug target for cancer therapy","volume":"17","author":"Xu","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0220","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/ng0996-95","article-title":"Leptin activation of Stat3 in the hypothalamus of wild-type and ob\/ob mice but not db\/db mice","volume":"14","author":"Vaisse","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0225","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1182\/blood.V84.6.1760.1760","article-title":"Rapid activation of the STAT3 transcription factor by granulocyte colony-stimulating factor","volume":"84","author":"Tian","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0230","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1126\/science.8140422","article-title":"Jr Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6","volume":"264","author":"Zhong","year":"1994","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0235","doi-asserted-by":"crossref","first-page":"16975","DOI":"10.1073\/pnas.1315862110","article-title":"STAT3 activation in response to IL-6 is prolonged by the binding of IL-6 receptor to EGF receptor","volume":"110","author":"Wang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0240","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1128\/MCB.16.4.1759","article-title":"Platelet-derived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins","volume":"16","author":"Vignais","year":"1996","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0245","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1182\/blood.V86.8.2948.2948","article-title":"Colony-stimulating factor 1-induced STAT1 and STAT3 activation is accompanied by phosphorylation of Tyk2 in macrophages and Tyk2 and JAK1 in fibroblasts","volume":"86","author":"Novak","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0250","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1146\/annurev.immunol.22.012703.104622","article-title":"Interleukin-10 and related cytokines and receptors","volume":"22","author":"Pestka","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0255","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0898-6568(03)00003-2","article-title":"IL-2 activation of a PI3K-dependent STAT3 serine phosphorylation pathway in primary human T cells","volume":"15","author":"Fung","year":"2003","journal-title":"Cell Signal."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0260","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3390\/cancers6020958","article-title":"STAT3 Activity and Function in Cancer: modulation by STAT5 and miR-146b","volume":"6","author":"Walker","year":"2014","journal-title":"Cancers"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0265","doi-asserted-by":"crossref","first-page":"ra11","DOI":"10.1126\/scisignal.2004497","article-title":"STAT3 induction of miR-146b forms a feedback loop to inhibit the NF-\u03baB to IL-6 signaling axis and STAT3-driven cancer phenotypes","volume":"7","author":"Xiang","year":"2014","journal-title":"Sci. Signal."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0270","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/humrep\/deu332","article-title":"Enhanced miR-210 expression promotes the pathogenesis of endometriosis through activation of signal transducer and activator of transcription 3","volume":"30","author":"Okamoto","year":"2015","journal-title":"Hum. Reprod. (Oxford, England)"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0275","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1128\/MCB.16.4.1595","article-title":"Activation and association of Stat3 with Src in v-Src-transformed cell lines","volume":"16","author":"Cao","year":"1996","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0280","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1038\/sj.onc.1204186","article-title":"G protein coupled receptor signaling through the Src and Stat3 pathway: role in proliferation and transformation","volume":"20","author":"Ram","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0285","doi-asserted-by":"crossref","first-page":"8017","DOI":"10.1038\/sj.onc.1208159","article-title":"Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis","volume":"23","author":"Silva","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0290","doi-asserted-by":"crossref","first-page":"9014","DOI":"10.1073\/pnas.161281298","article-title":"Rac1 mediates STAT3 activation by autocrine IL-6","volume":"98","author":"Faruqi","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0295","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1091\/mbc.12.10.3282","article-title":"Simultaneous tyrosine and serine phosphorylation of STAT3 transcription factor is involved in Rho A GTPase oncogenic transformation","volume":"12","author":"Aznar","year":"2001","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0300","doi-asserted-by":"crossref","first-page":"5948","DOI":"10.1073\/pnas.86.15.5948","article-title":"Fatal syndrome in mice engrafted with cells producing high levels of the leukemia inhibitory factor","volume":"86","author":"Metcalf","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0305","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1349-7006.1995.tb02435.x","article-title":"Cytokine production in five tumor cell lines with activity to induce cancer cachexia syndrome in nude mice","volume":"86","author":"Iseki","year":"1995","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0310","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1006\/cyto.2001.0968","article-title":"Cancer cachexia is mediated in part by the induction of IL-6-like cytokines from the spleen","volume":"16","author":"Barton","year":"2001","journal-title":"Cytokine"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0315","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1172\/JCI117276","article-title":"Systemic administration of ciliary neurotrophic factor induces cachexia in rodents","volume":"93","author":"Henderson","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0320","first-page":"94","article-title":"Prevention of adenocarcinoma colon 26-induced cachexia by interleukin 10 gene transfer","volume":"57","author":"Fujiki","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0325","first-page":"562","article-title":"Proteolysis-inducing factor regulates hepatic gene expression via the transcription factors NF-(kappa)B and STAT3","volume":"15","author":"Watchorn","year":"2001","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-14-997","article-title":"Genome-wide identification of FoxO-dependent gene networks in skeletal muscle during C26 cancer cachexia","volume":"14","author":"Judge","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0335","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1093\/nar\/gks1300","article-title":"Distinct transcriptional regulatory modules underlie STAT3\u2019s cell type-independent and cell type-specific functions","volume":"41","author":"Hutchins","year":"2013","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0340","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1096\/fj.11-189977","article-title":"Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy","volume":"26","author":"Reed","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0345","doi-asserted-by":"crossref","first-page":"41114","DOI":"10.1074\/jbc.M400674200","article-title":"Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated type I. (Slow Twitch\/Red Muscle) Fiber genes, and impaired glycemic control","volume":"279","author":"Kamei","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0350","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1097-2765(04)00211-4","article-title":"The IGF-1\/PI3K\/Akt Pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors","volume":"14","author":"Stitt","year":"2004","journal-title":"Mol. Cell."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0355","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0092-8674(04)00400-3","article-title":"Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy","volume":"117","author":"Sandri","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0360","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.bbagrm.2014.07.010","article-title":"Integration of genome-wide of Stat3 binding and epigenetic modification mapping with transcriptome reveals novel Stat3 target genes in glioma cells","volume":"1839","author":"Kruczyk","year":"2014","journal-title":"Biochim. Biophys. Acta (BBA) \u2013 Gene Regul. Mechanisms"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0365","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.immuni.2010.05.003","article-title":"Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis","volume":"32","author":"Durant","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0370","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1074\/jbc.M706976200","article-title":"Identification of novel direct Stat3 target genes for control of growth and differentiation","volume":"283","author":"Snyder","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0375","doi-asserted-by":"crossref","first-page":"e6911","DOI":"10.1371\/journal.pone.0006911","article-title":"Prediction and experimental validation of novel STAT3 target genes in human cancer cells","volume":"4","author":"Oh","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0380","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.4161\/cbt.3.11.1172","article-title":"Genome-wide analysis of STAT target genes: elucidating the mechanism of STAT-mediated oncogenesis","volume":"3","author":"Alvarez","year":"2004","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0385","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1038\/sj.onc.1208469","article-title":"Stat3 regulates genes common to both wound healing and cancer","volume":"24","author":"Dauer","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0390","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1172\/JCI59408","article-title":"Hepatocyte-specific mutation of both NF-kappaB RelA and STAT3 abrogates the acute phase response in mice","volume":"122","author":"Quinton","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0395","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1002\/hep.21837","article-title":"Signal transducer and activator of transcription 3 signaling within hepatocytes attenuates systemic inflammatory response and lethality in septic mice","volume":"46","author":"Sakamori","year":"2007","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0400","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ejcb.2011.09.008","article-title":"Hepatic acute phase proteins\u2013regulation by IL-6- and IL-1-type cytokines involving STAT3 and its crosstalk with NF-kappaB-dependent signaling","volume":"91","author":"Bode","year":"2012","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0405","doi-asserted-by":"crossref","first-page":"9394","DOI":"10.1073\/pnas.1511711112","article-title":"Opposing roles of STAT1 and STAT3 in IL-21 function in CD4+ T cells","volume":"112","author":"Wan","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0410","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.atherosclerosis.2014.02.029","article-title":"Modulation of vascular smooth muscle cell phenotype by STAT-1 and STAT-3","volume":"234","author":"Kirchmer","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0415","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1002\/eji.201445344","article-title":"Gain-of-function STAT1 mutations impair STAT3 activity in patients with chronic mucocutaneous candidiasis (CMC)","volume":"45","author":"Zheng","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0420","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1128\/MCB.9.9.4109","article-title":"Autoregulation of interleukin 6 and granulocyte-macrophage colony-stimulating factor in the differentiation of myeloid leukemic cells","volume":"9","author":"Shabo","year":"1989","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0425","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.1128\/MCB.21.19.6615-6625.2001","article-title":"Tissue-specific autoregulation of thestat3 gene and its role in interleukin-6-induced survival signals in T cells","volume":"21","author":"Narimatsu","year":"2001","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0430","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2009.10.014","article-title":"An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation","volume":"139","author":"Iliopoulos","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0435","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1182\/blood-2005-08-007377","article-title":"STAT3 induces transcription of the DNA methyltransferase 1 gene (DNMT1) in malignant T lymphocytes","volume":"108","author":"Zhang","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0440","doi-asserted-by":"crossref","first-page":"6948","DOI":"10.1073\/pnas.0501959102","article-title":"STAT3- and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes","volume":"102","author":"Zhang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0445","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1756-8935-8-7","article-title":"STAT3 acts through pre-existing nucleosome-depleted regions bound by FOS during an epigenetic switch linking inflammation to cancer","volume":"8","author":"Fleming","year":"2015","journal-title":"Epigenet. Chromatin"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0450","doi-asserted-by":"crossref","first-page":"13457","DOI":"10.1073\/pnas.1408023111","article-title":"Stat3 promotes IL-10 expression in lupus T cells through trans-activation and chromatin remodeling","volume":"111","author":"Hedrich","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0455","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/stem.1225","article-title":"Jak\/Stat3 signaling promotes somatic cell reprogramming by epigenetic regulation","volume":"30","author":"Tang","year":"2012","journal-title":"Stem Cells"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0460","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/ijc.25764","article-title":"Interleukin-6 promotes tumorigenesis by altering DNA methylation in oral cancer cells","volume":"129","author":"Gasche","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0465","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.metabol.2010.12.008","article-title":"copy number is modulated by genetic variation in the signal transducer and activator of transcription 3 (STAT3)","volume":"60","author":"Gianotti","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0470","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1080\/1042819022386716","article-title":"Role of the Leukemia-associated Transcription Factor STAT3 in Platelet Physiology","volume":"43","author":"Vassilev","year":"2002","journal-title":"Leukemia Lymphoma"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0475","doi-asserted-by":"crossref","first-page":"23532","DOI":"10.1074\/jbc.C110.152652","article-title":"Stoichiometry of STAT3 and mitochondrial proteins: implications for the regulation of oxidative phosphorylation by protein-protein interactions","volume":"285","author":"Phillips","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0480","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1126\/science.1164551","article-title":"Function of mitochondrial Stat3 in cellular respiration","volume":"323","author":"Wegrzyn","year":"2009","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0485","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1126\/science.1171721","article-title":"Mitochondrial Stat3 supports ras-dependent oncogenic transformation","volume":"324","author":"Gough","year":"2009","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0490","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00395-010-0124-1","article-title":"Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia\/reperfusion","volume":"105","author":"Boengler","year":"2010","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0495","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.4161\/cc.9.21.13677","article-title":"Could STAT3 provide a link between respiration and cell cycle progression","volume":"9","author":"Shaw","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0500","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s13539-012-0062-x","article-title":"Inflammation, organomegaly, and muscle wasting despite hyperphagia in a mouse model of burn cachexia","volume":"3","author":"Pedroso","year":"2012","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0505","doi-asserted-by":"crossref","first-page":"e21245","DOI":"10.1371\/journal.pone.0021245","article-title":"Long-term persistance of the pathophysiologic response to severe burn injury","volume":"6","author":"Jeschke","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0510","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cyto.2008.10.005","article-title":"Cytokine expression profile over time in burned mice","volume":"45","author":"Finnerty","year":"2009","journal-title":"Cytokine"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0515","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/SLA.0b013e3181856241","article-title":"Pathophysiologic response to severe burn injury","volume":"248","author":"Jeschke","year":"2008","journal-title":"Ann. Surg."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0520","doi-asserted-by":"crossref","first-page":"S354","DOI":"10.1097\/CCM.0b013e3181b6e439","article-title":"Sepsis-induced myopathy","volume":"37","author":"Callahan","year":"2009","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0525","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc10475","article-title":"Plasma from septic shock patients induces loss of muscle protein","volume":"15","author":"van Hees","year":"2011","journal-title":"Crit. Care"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0530","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1152\/physrev.00028.2014","article-title":"The sick and the weak: neuropathies\/myopathies in the critically ill","volume":"95","author":"Friedrich","year":"2015","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0535","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1152\/japplphysiol.00790.2012","article-title":"The mechanisms of cachexia underlying muscle dysfunction in COPD","volume":"114","author":"Remels","year":"2013","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0540","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bone.2015.03.015","article-title":"Inflammation induced loss of skeletal muscle","volume":"80","author":"Londhe","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0545","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/1440-1681.12357","article-title":"Systematic review of anaemia and inflammatory markers in chronic obstructive pulmonary disease","volume":"42","author":"Hoepers","year":"2015","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0550","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jacc.2014.04.083","article-title":"Metabolic impairment in heart failure: the myocardial and systemic perspective","volume":"64","author":"Doehner","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0555","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/SPC.0000000000000030","article-title":"Molecular mechanisms and treatment targets of muscle wasting and cachexia in heart failure: an overview","volume":"8","author":"Ebner","year":"2014","journal-title":"Curr. Opin. Support Palliat. Care"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0560","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1755-6686.2013.00341.x","article-title":"A literature review of end-stage renal disease and cachexia: understanding experience to inform evidence-based healthcare","volume":"39","author":"Reid","year":"2013","journal-title":"J. Ren. Care"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0565","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/phar.1431","article-title":"Pharmacologic management of human immunodeficiency virus wasting syndrome","volume":"34","author":"Badowski","year":"2014","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0570","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/SPC.0b013e3283186be2","article-title":"Cachexia, survival and the acute phase response","volume":"2","author":"Stephens","year":"2008","journal-title":"Curr. Opin. Support. Palliative Care"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0575","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00000658-197308000-00019","article-title":"Weight loss following thermal injury","volume":"178","author":"Newsome","year":"1973","journal-title":"Ann. Surg."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0580","doi-asserted-by":"crossref","first-page":"e83618","DOI":"10.1371\/journal.pone.0083618","article-title":"Clinical classification of cancer cachexia: phenotypic correlates in human skeletal muscle","volume":"9","author":"Johns","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0585","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0590","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.12077","article-title":"MAP3K11\/GDF15 axis is a critical driver of cancer cachexia","author":"Lerner","year":"2015","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0595","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/jcsm.12033","article-title":"Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients","volume":"6","author":"Lerner","year":"2015","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0600","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1210\/jc.2014-4318","article-title":"Role of activin A and myostatin in human cancer cachexia","volume":"100","author":"Loumaye","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0605","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S1499-3872(14)60259-9","article-title":"Interleukin-6: a villain in the drama of pancreatic cancer development and progression","volume":"13","author":"Holmer","year":"2014","journal-title":"Hepatobiliary Pancreatic Dis. Int."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0610","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s12041-014-0405-9","article-title":"Genetic basis of interindividual susceptibility to cancer cachexia: selection of potential candidate gene polymorphisms for association studies","volume":"93","author":"Johns","year":"2014","journal-title":"J. Genet."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0615","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/1471-2407-14-357","article-title":"Genetic modulation of the interleukin 6 (IL-6) system in patients with advanced gastric cancer: a background for an alternative target therapy","volume":"14","author":"Ruzzo","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0620","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/SPC.0b013e32833e4a5d","article-title":"Cytokine gene polymorphisms and susceptibility to cachexia","volume":"4","author":"Tan","year":"2010","journal-title":"Curr. Opin. Support. Palliative Care"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0625","article-title":"Protein breakdown in cancer cachexia","author":"Sandri","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0630","article-title":"Impaired regeneration: a role for the musclemicroenvironment in cancer cachexia","author":"Talbert","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0635","article-title":"Lipolytic and thermogenicdepletion of adipose tissue in cancer cachexia","author":"Tsoli","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0640","article-title":"The central role of hypothalamicinflammation in the acute illness response and cachexia","author":"Burfeind","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0645","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s13539-013-0111-0","article-title":"Why cachexia kills: examining the causality of poor outcomes in wasting conditions Journal of Cachexia","volume":"4","author":"Kalantar-Zadeh","year":"2013","journal-title":"Sarcopenia Muscle"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0650","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3945\/ajcn.111.014639","article-title":"High platelet count as a link between renal cachexia and cardiovascular mortality in end-stage renal disease patients","volume":"94","author":"Molnar","year":"2011","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0655","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1017\/S0007114512001067","article-title":"Accelerated muscle and adipose tissue loss may predict survival in pancreatic cancer patients: the relationship with diabetes and anaemia","volume":"109","author":"Di Sebastiano","year":"2013","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0660","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1210\/endo-128-5-2657","article-title":"Chinese hamster ovarian cells transfected with the murine lnterleukin-6 gene cause hypercalcemia as well as cachexia, leukocytosis and thrombocytosis in tumor-bearing nude mice","volume":"128","author":"Black","year":"1991","journal-title":"Endocrinology"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0665","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jacc.2014.07.948","article-title":"Cardiovascular function and predictors of exercise capacity in patients with colorectal cancer","volume":"64","author":"Cramer","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0670","doi-asserted-by":"crossref","first-page":"212265","DOI":"10.7573\/dic.212265","article-title":"One-year prevalence, comorbidities and cost of cachexia-related inpatient admissions in the USA","volume":"3","author":"Arthur","year":"2014","journal-title":"Drugs Context"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0675","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s13539-014-0137-y","article-title":"Concurrent evolution of cancer cachexia and heart failure: bilateral effects exist","volume":"5","author":"Kazemi-Bajestani","year":"2014","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0680","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/blood-2014-09-602763","article-title":"Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations","volume":"125","author":"Milner","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0685","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1152\/physiolgenomics.00128.2014","article-title":"Cardiac and skeletal muscles show molecularly distinct responses to cancer cachexia","volume":"47","author":"Shum","year":"2015","journal-title":"Physiol. Genom."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0690","doi-asserted-by":"crossref","first-page":"djv274","DOI":"10.1093\/jnci\/djv274","article-title":"Preclinical investigation of the novel histone deacetylase inhibitor AR-42 in the treatment of cancer-induced cachexia","volume":"107","author":"Tseng","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0695","doi-asserted-by":"crossref","first-page":"e24650","DOI":"10.1371\/journal.pone.0024650","article-title":"The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the Apc(Min\/+) mouse","volume":"6","author":"White","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0700","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jtcvs.2011.02.025","article-title":"Gene expression changes in the human diaphragm after cardiothoracic surgery","volume":"142","author":"Huang","year":"2011","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0705","first-page":"3557","article-title":"Bioinformatics analysis of molecular mechanisms of chronic obstructive pulmonary disease","volume":"18","author":"Chen","year":"2014","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0710","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.cmet.2013.07.012","article-title":"Stat3 activation links a C\/EBPdelta to myostatin pathway to stimulate loss of muscle mass","volume":"18","author":"Zhang","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0715","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1089\/rej.2007.0588","article-title":"Human sarcopenia reveals an increase in SOCS-3 and myostatin and a reduced efficiency of Akt phosphorylation","volume":"11","author":"Leger","year":"2008","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0720","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/SLA.0b013e31823e76e7","article-title":"Severe injury is associated with insulin resistance, endoplasmic reticulum stress response, and unfolded protein response","volume":"255","author":"Jeschke","year":"2012","journal-title":"Ann. Surg."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0725","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/BCR.0b013e3182331e4b","article-title":"Inflammatory and protein metabolism signaling responses in human skeletal muscle after burn injury","volume":"33","author":"Merritt","year":"2012","journal-title":"J. Burn Care Res. Off. Publ. Am. Burn Assoc."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0730","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.molmet.2015.05.001","article-title":"Knockout of STAT3 in skeletal muscle does not prevent high-fat diet-induced insulin resistance","volume":"4","author":"White","year":"2015","journal-title":"Mol. Metab."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0735","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/jn\/128.8.1355","article-title":"Fibrinogen synthesis is elevated in fasting cancer patients with an acute phase response","volume":"128","author":"Preston","year":"1998","journal-title":"J. Nutr."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0740","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1172\/JCI68523","article-title":"NF-\u03baB\u2013mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia","volume":"123","author":"He","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0745","doi-asserted-by":"crossref","first-page":"e13604","DOI":"10.1371\/journal.pone.0013604","article-title":"Muscle wasting and impaired myogenesis in tumor bearing mice are prevented by ERK inhibition","volume":"5","author":"Penna","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0750","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1083\/jcb.200703184","article-title":"JAK1-STAT1-STAT3, a key pathway promoting proliferation and preventing premature differentiation of myoblasts","volume":"179","author":"Sun","year":"2007","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0755","doi-asserted-by":"crossref","first-page":"34029","DOI":"10.1074\/jbc.M803012200","article-title":"JAK2\/STAT2\/STAT3 are required for myogenic differentiation","volume":"283","author":"Wang","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0760","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/nm.3656","article-title":"STAT3 signaling controls satellite cell expansion and skeletal muscle repair","volume":"20","author":"Tierney","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0765","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/nm.3655","article-title":"Inhibition of JAK-STAT signaling stimulates adult satellite cell function","volume":"20","author":"Price","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0770","doi-asserted-by":"crossref","first-page":"44178","DOI":"10.1074\/jbc.M304884200","article-title":"Reciprocal inhibition between MyoD and STAT3 in the regulation of growth and differentiation of myoblasts","volume":"278","author":"Kataoka","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0775","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.cyto.2008.12.015","article-title":"STAT3 induces muscle stem cell differentiation by interaction with myoD","volume":"46","author":"Yang","year":"2009","journal-title":"Cytokine"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0780","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature08712","article-title":"The transcriptional network for mesenchymal transformation of brain tumours","volume":"463","author":"Carro","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0785","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ccr.2011.03.009","article-title":"Stat3\/Socs3 activation by IL-6 transsignaling promotesprogression of pancreatic intraepithelial neoplasia and development ofpancreatic cancer","volume":"19","author":"Lesina","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0790","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1158\/0008-5472.CAN-11-0908","article-title":"STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis","volume":"71","author":"Corcoran","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0795","article-title":"Constitutive activation of STAT3 in breast cancer cells:a review","author":"Banerjee","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0800","first-page":"6659","article-title":"Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells","volume":"62","author":"Mora","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0805","first-page":"907","article-title":"The role of Stat3 in glioblastoma multiforme","volume":"20","author":"Luwor","year":"2013","journal-title":"J. Clin. Neurosci. Off. J. Neurosurg. Soc. Australas."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0810","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.cytogfr.2015.07.010","article-title":"Mutations leading to constitutive active gp130\/JAK1\/STAT3 pathway","volume":"26","author":"Pilati","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0815","doi-asserted-by":"crossref","first-page":"626","DOI":"10.2174\/156652409788488720","article-title":"STAT3 as a central regulator of tumor metastases","volume":"9","author":"Devarajan","year":"2009","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0820","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1158\/0008-5472.CAN-09-2468","article-title":"Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells","volume":"70","author":"Lin","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0825","doi-asserted-by":"crossref","first-page":"e47462","DOI":"10.1371\/journal.pone.0047462","article-title":"APE1\/Ref-1 regulates STAT3 transcriptional activity and APE1\/Ref-1-STAT3 dual-targeting effectively inhibits pancreatic cancer cell survival","volume":"7","author":"Cardoso","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0830","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.bcp.2010.01.001","article-title":"A novel small-molecule disrupts Stat3 SH2 domain-phosphotyrosine interactions and Stat3-dependent tumor processes","volume":"79","author":"Zhang","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0835","doi-asserted-by":"crossref","first-page":"708","DOI":"10.3390\/cancers6020708","article-title":"The role of STAT3 in non-small cell lung cancer","volume":"6","author":"Harada","year":"2014","journal-title":"Cancers"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0840","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2217\/hep.13.7","article-title":"STAT3 in hepatocellular carcinoma: new perspectives","volume":"1","author":"Svinka","year":"2013","journal-title":"Hepatic Oncol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0845","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/jhbp.131","article-title":"STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression","volume":"21","author":"Dokduang","year":"2014","journal-title":"J. Hepato\u2013Biliary\u2013Pancreatic Sci."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0850","first-page":"283","article-title":"Activation of Stat3 in renal tumors","volume":"1","author":"Guo","year":"2009","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0855","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1158\/1535-7163.MCT-14-0077","article-title":"Targeting JAK1\/STAT3 signaling suppresses tumor progression and metastasis in a peritoneal model of human ovarian cancer","volume":"13","author":"Wen","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0860","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cytogfr.2006.01.002","article-title":"Transcriptional anti-angiogenesis therapy of human pancreatic cancer","volume":"17","author":"Xie","year":"2006","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0865","doi-asserted-by":"crossref","first-page":"e24891","DOI":"10.4161\/onci.24891","article-title":"Pancreatic cancer-associated stellate cells: a viable target for reducing immunosuppression in the tumor microenvironment","volume":"2","author":"Mace","year":"2013","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0870","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1302895","article-title":"Novel role for tumor-induced expansion of myeloid-derived cells in cancer cachexia","author":"Cuenca","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0875","doi-asserted-by":"crossref","first-page":"7504","DOI":"10.18632\/oncotarget.3233","article-title":"TCGA data and patient-derived orthotopic xenografts highlight pancreatic cancer-associated angiogenesis","volume":"6","author":"Gore","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0880","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1053\/j.gastro.2015.07.058","article-title":"Signal transducer and activator of transcription 3, mediated remodeling of the tumor microenvironment results in enhanced tumor drug delivery in a mouse model of pancreatic cancer","volume":"149","author":"Nagathihalli","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0885","doi-asserted-by":"crossref","first-page":"801685","DOI":"10.1155\/2015\/801685","article-title":"Contribution of Neuroinflammation to the Pathogenesis of Cancer Cachexia","volume":"2015","author":"Molfino","year":"2015","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0890","doi-asserted-by":"crossref","first-page":"e23675","DOI":"10.4161\/jkst.23675","article-title":"JAK-STAT and feeding","volume":"2","author":"Ladyman","year":"2013","journal-title":"JAK-STAT"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0895","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nm1071","article-title":"Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity","volume":"10","author":"Mori","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0900","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1210\/en.2007-0945","article-title":"Signal transducer and activator of transcription-3 is required in hypothalamic agouti-related protein\/neuropeptide Y neurons for normal energy homeostasis","volume":"149","author":"Gong","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0905","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.cmet.2011.09.011","article-title":"Elevated hypothalamic TCPTP in obesity contributes to cellular leptin resistance","volume":"14","author":"Loh","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0910","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.cmet.2012.11.005","article-title":"Tyk2 and Stat3 regulate brown adipose tissue differentiation and obesity","volume":"16","author":"Derecka","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0915","doi-asserted-by":"crossref","first-page":"73","DOI":"10.12703\/P6-73","article-title":"Leptin signaling","volume":"6","author":"Park","year":"2014","journal-title":"F1000Prime Rep."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0920","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cmet.2014.06.011","article-title":"A switch from white to brown fat increases energy expenditure in cancer-associated cachexia","volume":"20","author":"Petruzzelli","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0925","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/1097-0142(197808)42:2<453::AID-CNCR2820420212>3.0.CO;2-T","article-title":"A comparative study of the influence of malignant tumor on host metabolism in mice and man. Evaluation of an experimental model","volume":"42","author":"Lundholm","year":"1978","journal-title":"Cancer"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0930","first-page":"4657","article-title":"Protein synthesis in liver tissue under the influence of a methylcholanthrene-induced sarcoma in mice","volume":"39","author":"Lundholm","year":"1979","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0935","first-page":"213","article-title":"Transcriptional and translational activity in relation to oxygen consumption in isolated liver cells from sarcoma-bearing mice","volume":"6","author":"Ternell","year":"1983","journal-title":"Cancer Biochem. Biophys."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0940","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/BF02303570","article-title":"Effect of growth hormone on tumor and host in an animal model","volume":"1","author":"Wolf","year":"1994","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0945","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1042\/bj2410153","article-title":"Early development of protein metabolic perturbations in the liver and skeletal muscle of tumour-bearing rats. A model system for cancer cachexia","volume":"241","author":"Tessitore","year":"1987","journal-title":"Biochem. J."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0950","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1053\/jhep.2003.50318","article-title":"Massive liver growth in mice induced by systemic interleukin 6 administration","volume":"38","author":"Zimmers","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0955","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.devcel.2015.03.001","article-title":"Malignant Drosophila tumors interrupt insulin signaling to induce cachexia-like wasting","volume":"33","author":"Figueroa-Clarevega","year":"2015","journal-title":"Dev. Cell"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0960","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.devcel.2015.02.012","article-title":"Systemic organ wasting induced by localized expression of the secreted insulin\/IGF antagonist ImpL2","volume":"33","author":"Kwon","year":"2015","journal-title":"Dev. Cell"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0965","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/emmm.201201869","article-title":"TSC22D4 is a molecular output of hepatic wasting metabolism","volume":"5","author":"Jones","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0970","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/hep.21728","article-title":"Interleukin-6 inhibits oxidative injury and necrosis after extreme liver resection","volume":"46","author":"Jin","year":"2007","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0975","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/hep.21087","article-title":"Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair","volume":"43","author":"Jin","year":"2006","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0980","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/labinvest.3700630","article-title":"Role of STAT3 in liver regeneration: survival, DNA synthesis, inflammatory reaction and liver mass recovery","volume":"87","author":"Moh","year":"2007","journal-title":"Lab. Invest. J. Tech. Methods Pathol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0985","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.ajpath.2011.05.005","article-title":"Hepatoprotective versus oncogenic functions of STAT3 in liver tumorigenesis","volume":"179","author":"Wang","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib0990","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/1471-2407-10-363","article-title":"Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse","volume":"10","author":"Aulino","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semcdb.2016.02.009_bib0995","first-page":"231","article-title":"Characterization of a murine lung adenocarcinoma (LAC1), a useful experimental model to study progression of lung cancer","volume":"9","author":"Piegari","year":"2011","journal-title":"J. Exp. Ther. Oncol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib1000","first-page":"201","article-title":"Stromal cells of the mouse spleen","volume":"3","author":"den Haan","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib1005","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s13539-014-0153-y","article-title":"Formoterol in the treatment of experimental cancer cachexia: effects on heart function","volume":"5","author":"Toledo","year":"2014","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.semcdb.2016.02.009_bib1010","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.nut.2013.12.005","article-title":"Rosiglitazone reduces body wasting and improves survival in a rat model of cancer cachexia","volume":"30","author":"Trobec","year":"2014","journal-title":"Nutrition"},{"key":"10.1016\/j.semcdb.2016.02.009_bib1015","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.pathophys.2014.05.003","article-title":"Oxidative and proteolytic profiles of the right and left heart in a model of cancer-induced cardiac cachexia","volume":"21","author":"Borges","year":"2014","journal-title":"Pathophysiology"},{"key":"10.1016\/j.semcdb.2016.02.009_bib1020","first-page":"e24352","article-title":"Dancing rhinos in stilettos: the amazing saga of the genomic and nongenomic actions of STAT3 in the heart","volume":"2","author":"Zouein","year":"2013","journal-title":"JAKSTAT"},{"key":"10.1016\/j.semcdb.2016.02.009_bib1025","doi-asserted-by":"crossref","first-page":"12929","DOI":"10.1073\/pnas.2134694100","article-title":"Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age","volume":"100","author":"Jacoby","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcdb.2016.02.009_bib1030","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1161\/01.RES.0000134921.50377.61","article-title":"Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury","volume":"95","author":"Hilfiker-Kleiner","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.semcdb.2016.02.009_bib1035","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.cell.2006.12.036","article-title":"A cathepsin D-cleaved 16kDa form of prolactin mediates postpartum cardiomyopathy","volume":"128","author":"Hilfiker-Kleiner","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.semcdb.2016.02.009_bib1040","article-title":"Critical Roles of STAT3 in beta-adrenergic functions in the heart","author":"Zhang","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.semcdb.2016.02.009_bib1045","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1182\/blood-2014-08-594572","article-title":"Deletion of Stat3 in hematopoietic cells enhances thrombocytosis and shortens survival in a JAK2-V617F mouse model of MPN","volume":"125","author":"Grisouard","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.semcdb.2016.02.009_bib1050","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/CIRCULATIONAHA.112.132126","article-title":"Signal transducer and activator of transcription 3 (STAT3) regulates collagen-induced platelet aggregation independently of its transcription factor activity","volume":"127","author":"Zhou","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.semcdb.2016.02.009_bib1055","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S1470-2045(14)70319-5","article-title":"Siltuximab for multicentric Castleman\u2019s disease: a randomised, double-blind, placebo-controlled trial","volume":"15","author":"van Rhee","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib1060","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1172\/JCI57158","article-title":"Therapeutic strategies for the clinical blockade of IL-6\/gp130 signaling","volume":"121","author":"Jones","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.semcdb.2016.02.009_bib1065","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1517\/17425255.2015.992779","article-title":"Tocilizumab for treating rheumatoid arthritis: an evaluation of pharmacokinetics\/pharmacodynamics and clinical efficacy","volume":"11","author":"Song","year":"2015","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib1070","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/SPC.0000000000000017","article-title":"Gut barrier dysfunction and microbial translocation in cancer cachexia: a new therapeutic target","volume":"7","author":"Klein","year":"2013","journal-title":"Curr. Opin. Support Palliat. Care"},{"key":"10.1016\/j.semcdb.2016.02.009_bib1075","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.coi.2015.02.008","article-title":"The IL-6\/gp130\/STAT3 signaling axis: recent advances towards specific inhibition","volume":"34","author":"Garbers","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib1080","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/nrd3094","article-title":"Deal watch: BMS acquires rights for IL-6 inhibitor","volume":"9","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.semcdb.2016.02.009_bib1085","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.immuni.2004.07.020","article-title":"TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling","volume":"21","author":"Becker","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.semcdb.2016.02.009_bib1090","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.4049\/jimmunol.171.6.3202","article-title":"Soluble IL-6 receptor governs IL-6 activity in experimental arthritis: blockade of arthritis severity by soluble glycoprotein 130","volume":"171","author":"Nowell","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib1095","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4049\/jimmunol.182.1.613","article-title":"Therapeutic targeting of IL-6 trans signaling counteracts STAT3 control of experimental inflammatory arthritis","volume":"182","author":"Nowell","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib1100","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/00001813-200507000-00002","article-title":"Targeting Stat3 in cancer therapy","volume":"16","author":"Jing","year":"2005","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.semcdb.2016.02.009_bib1105","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.semcdb.2008.07.020","article-title":"The JAK kinases: not just another kinase drug discovery target","volume":"19","author":"Wilks","year":"2008","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib1110","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1182\/blood-2009-10-246363","article-title":"Phase 2 study of CEP-701, an orally available JAK2 inhibitor, in patients with primary or post-polycythemia vera\/essential thrombocythemia myelofibrosis","volume":"115","author":"Santos","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.semcdb.2016.02.009_bib1115","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/bjc.2012.144","article-title":"Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: selumetinib in patients with cholangiocarcinoma","volume":"106","author":"Prado","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.semcdb.2016.02.009_bib1120","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.18632\/oncotarget.2812","article-title":"Sunitinib prevents cachexia and prolongs survival of mice bearing renal cancer by restraining STAT3 and MuRF-1 activation in muscle","volume":"6","author":"Pretto","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcdb.2016.02.009_bib1125","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1517\/13543780802565791","article-title":"Targeting STAT3 in cancer: how successful are we","volume":"18","author":"Yue","year":"2009","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.semcdb.2016.02.009_bib1130","doi-asserted-by":"crossref","first-page":"35855","DOI":"10.1074\/jbc.M110.154088","article-title":"A cell-permeable Stat3 SH2 domain mimetic inhibits Stat3 activation and induces antitumor cell effects in vitro","volume":"285","author":"Zhao","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcdb.2016.02.009_bib1135","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1139\/O09-044","article-title":"Molecular disruption of oncogenic signal transducer and activator of transcription 3 (STAT3) protein","volume":"87","author":"Fletcher","year":"2009","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib1140","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/ijc.28429","article-title":"STAT3 inhibition sensitizes colorectal cancer to chemoradiotherapy in vitro and in vivo","volume":"134","author":"Spitzner","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcdb.2016.02.009_bib1145","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/leu.2014.245","article-title":"Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia","volume":"29","author":"Eiring","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.semcdb.2016.02.009_bib1150","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1021\/ml4003138","article-title":"Potent targeting of the STAT3 protein in brain cancer stem cells: a promising route for treating glioblastoma","volume":"4","author":"Haftchenary","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.semcdb.2016.02.009_bib1155","doi-asserted-by":"crossref","first-page":"9623","DOI":"10.1073\/pnas.1121606109","article-title":"Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts","volume":"109","author":"Zhang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcdb.2016.02.009_bib1160","doi-asserted-by":"crossref","first-page":"e40724","DOI":"10.1371\/journal.pone.0040724","article-title":"Structurally modified curcumin analogs inhibit STAT3 phosphorylation and promote apoptosis of human renal cell carcinoma and melanoma cell lines","volume":"7","author":"Bill","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.semcdb.2016.02.009_bib1165","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1158\/0008-5472.CAN-12-4601","article-title":"Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner","volume":"73","author":"Mace","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcdb.2016.02.009_bib1170","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1021\/cb500071v","article-title":"A small molecule compound targeting STAT3 DNA-binding domain inhibits cancer cell proliferation, migration, and invasion","volume":"9","author":"Huang","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib1175","doi-asserted-by":"crossref","first-page":"15969","DOI":"10.1074\/jbc.M114.564252","article-title":"Galiellalactone is a direct inhibitor of the transcription factor STAT3 in prostate cancer cells","volume":"289","author":"Don-Doncow","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcdb.2016.02.009_bib1180","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1074\/jbc.R300030200","article-title":"Inhibitors of cytokine signal transduction","volume":"279","author":"Wormald","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcdb.2016.02.009_bib1185","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.semcdb.2008.07.010","article-title":"SOCS regulation of the JAK\/STAT signalling pathway","volume":"19","author":"Croker","year":"2008","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.semcdb.2016.02.009_bib1190","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0006-291X(02)02291-X","article-title":"The nuclear isoform of protein-tyrosine phosphatase TC-PTP regulates interleukin-6-mediated signaling pathway through STAT3 dephosphorylation","volume":"297","author":"Yamamoto","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.semcdb.2016.02.009_bib1195","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ccr.2009.10.015","article-title":"The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors","volume":"16","author":"Hedvat","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcdb.2016.02.009_bib1200","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1634\/theoncologist.2013-0198","article-title":"AZD1480: a phase I study of a novel JAK2 inhibitor in solid tumors","volume":"18","author":"Plimack","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.semcdb.2016.02.009_bib1205","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1182\/blood-2009-04-214957","article-title":"Preclinical characterization of the selective JAK1\/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms","volume":"115","author":"Quintas-Cardama","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.semcdb.2016.02.009_bib1210","doi-asserted-by":"crossref","first-page":"e4783","DOI":"10.1371\/journal.pone.0004783","article-title":"Chemical probes that competitively and selectively inhibit Stat3 activation","volume":"4","author":"Xu","year":"2009","journal-title":"PLoS One"}],"container-title":["Seminars in Cell &amp; Developmental Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1084952116300519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1084952116300519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T19:56:01Z","timestamp":1692215761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1084952116300519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":242,"alternative-id":["S1084952116300519"],"URL":"https:\/\/doi.org\/10.1016\/j.semcdb.2016.02.009","relation":{},"ISSN":["1084-9521"],"issn-type":[{"value":"1084-9521","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"STAT3 in the systemic inflammation of cancer cachexia","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cell & Developmental Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcdb.2016.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}